People & Business :: M&A
Grovepoint acquires majority stake in biotech firm Algatechnologies
7:26 AM MST | February 19, 2013 | Natasha Alperowicz
Grovepoint (London), a private investment company, says it has acquired a majority stake in biotech company Algatechnologies (Hevel Eilot, Israel), a rapidly growing firm specializing in the commercial cultivation of microalgae and a leading manufacturer of natural astaxanthin AstaPure. Astaxanthin is a natural antioxidant with proven health benefits in several health conditions related to joint and muscle function, skin-care health, and cardiovascular health. The product is already well established in Japanese health food and increased recognition of its...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee